• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无预防治疗的血友病:关节活动范围及凝血因子活性评估

Hemophilia without prophylaxis: Assessment of joint range of motion and factor activity.

作者信息

Wang Michael, Recht Michael, Iyer Neeraj N, Cooper David L, Soucie J Michael

机构信息

Hemophilia and Thrombosis Center University of Colorado School of Medicine Aurora Colorado USA.

The Hemophilia Center at Oregon Health & Science University Portland Oregon USA.

出版信息

Res Pract Thromb Haemost. 2020 Jul 6;4(6):1035-1045. doi: 10.1002/rth2.12347. eCollection 2020 Aug.

DOI:10.1002/rth2.12347
PMID:32864554
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7443428/
Abstract

BACKGROUND

Recurrent joint bleeding in hemophilia results in arthropathy and functional impairment. The relationship of arthropathy development and factor activity (FA) has not been reported in patients with FA levels <15%-20%.

METHODS

During the Centers for Disease Control and Prevention Universal Data Collection, joint range-of-motion (ROM) measurements were taken at each comprehensive visit. Data were extracted from male patients with hemophilia (PWH) age ≥2 years with baseline factor activity levels ≤40%, excluding those prescribed prophylaxis, and used to calculate a proportion of normal ROM (PN-ROM) measure. Data were analyzed using regression models.

RESULTS

There were 6703 eligible PWH with 30 102 visits. PN-ROM declined with increasing age, and was associated with hemophilia severity, race/ethnicity, obesity, and viral illnesses. PWH ≥30 years old with fFA ≤2% and those ≥50 years old with FA ≤5% had mean PN-ROM values >10% less than controls; those ≥40 years old with FA <1% had values >20% less than controls. In the multivariable analysis, subjects with <1% FA had a 0.43% greater decrease (-0.49 to -0.37, 95% confidence interval) in PN-ROM each year relative to those with 16%-40% factor activity. A less pronounced effect was seen with 1%-5% or 6%-9% FA.

CONCLUSION

The effect of FA on ROM loss is far greater than that of any of the other characteristics, especially with FA <10%. This emphasizes the need to maintain a high index of suspicion for arthropathy in individuals with moderate and low-mild hemophilia.

摘要

背景

血友病患者反复关节出血会导致关节病和功能障碍。因子活性(FA)水平<15%-20%的患者中,关节病发展与因子活性的关系尚未见报道。

方法

在疾病控制和预防中心通用数据收集期间,每次综合就诊时均进行关节活动范围(ROM)测量。数据来自年龄≥2岁、基线因子活性水平≤40%的男性血友病患者(PWH),不包括接受预防治疗的患者,并用于计算正常ROM比例(PN-ROM)测量值。使用回归模型分析数据。

结果

共有6703例符合条件的PWH,进行了30102次就诊。PN-ROM随年龄增长而下降,并与血友病严重程度、种族/族裔、肥胖和病毒感染相关。fFA≤2%的30岁及以上PWH和FA≤5%的50岁及以上PWH的平均PN-ROM值比对照组低>10%;FA<1%的40岁及以上患者的PN-ROM值比对照组低>20%。在多变量分析中,与因子活性为16%-40%的受试者相比,FA<1%的受试者每年PN-ROM下降幅度大0.43%(-0.49至-0.37,95%置信区间)。FA为1%-5%或6%-9%时,效果不那么明显。

结论

FA对ROM丧失的影响远大于任何其他特征所造成的影响,尤其是FA<10%时。这强调了对中度和轻度血友病患者的关节病需保持高度怀疑指数。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/721e/7443428/3c359ee748af/RTH2-4-1035-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/721e/7443428/3c359ee748af/RTH2-4-1035-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/721e/7443428/3c359ee748af/RTH2-4-1035-g001.jpg

相似文献

1
Hemophilia without prophylaxis: Assessment of joint range of motion and factor activity.无预防治疗的血友病:关节活动范围及凝血因子活性评估
Res Pract Thromb Haemost. 2020 Jul 6;4(6):1035-1045. doi: 10.1002/rth2.12347. eCollection 2020 Aug.
2
Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors.血友病年轻男性的关节活动范围受限:患病率及危险因素
Blood. 2004 Apr 1;103(7):2467-73. doi: 10.1182/blood-2003-05-1457. Epub 2003 Nov 13.
3
Joint Function and Arthropathy Severity in Patients with Hemophilia.血友病患者的关节功能与关节病严重程度
J Jpn Phys Ther Assoc. 2015;18(1):15-22. doi: 10.1298/jjpta.Vol18_003.
4
Effect of late prophylaxis in hemophilia on joint status: a randomized trial.血友病晚期预防治疗对关节状况的影响:一项随机试验。
J Thromb Haemost. 2017 Nov;15(11):2115-2124. doi: 10.1111/jth.13811. Epub 2017 Oct 10.
5
Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.凝血因子浓缩物用于预防甲型或乙型血友病患者的出血及与出血相关的并发症。
Cochrane Database Syst Rev. 2005 Apr 18(2):CD003429. doi: 10.1002/14651858.CD003429.pub2.
6
Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.凝血因子浓缩物用于预防甲型或乙型血友病患者的出血及与出血相关的并发症。
Cochrane Database Syst Rev. 2006 Apr 19(2):CD003429. doi: 10.1002/14651858.CD003429.pub3.
7
Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B.用于预防既往接受过治疗的 A 型或 B 型血友病患者出血和出血相关并发症的凝血因子浓缩物。
Cochrane Database Syst Rev. 2021 Aug 18;8(8):CD014201. doi: 10.1002/14651858.CD014201.
8
Females with FVIII and FIX deficiency have reduced joint range of motion.患有凝血因子VIII和凝血因子IX缺乏症的女性关节活动范围减小。
Am J Hematol. 2014 Aug;89(8):831-6. doi: 10.1002/ajh.23754. Epub 2014 May 21.
9
Joint bleeds in mild hemophilia: Prevalence and clinical characteristics.轻度血友病中的关节出血:患病率和临床特征。
Haemophilia. 2024 Mar;30(2):331-335. doi: 10.1111/hae.14939. Epub 2024 Jan 19.
10
Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.凝血因子浓缩物用于预防甲型或乙型血友病患者的出血及与出血相关的并发症。
Cochrane Database Syst Rev. 2011 Sep 7(9):CD003429. doi: 10.1002/14651858.CD003429.pub4.

引用本文的文献

1
Real-World Evidence on Joint Condition in Non-Severe Hemophilia A Patients: A Multicenter Study.非重度甲型血友病患者关节状况的真实世界证据:一项多中心研究。
J Blood Med. 2025 May 19;16:251-258. doi: 10.2147/JBM.S517596. eCollection 2025.
2
Clinical and Humanistic Burden of Non-inhibitor Haemophilia A in Five European Countries: Insights from the CHESS II Study.五项欧洲国家非抑制性血友病 A 的临床与人文负担:来自 CHESS II 研究的洞察。
Adv Ther. 2024 Oct;41(10):3888-3904. doi: 10.1007/s12325-024-02956-0. Epub 2024 Aug 17.
3
Concizumab improves clot formation in hemophilia A under flow.

本文引用的文献

1
The frequency of joint hemorrhages and procedures in nonsevere hemophilia A vs B.非重度血友病 A 与 B 患者关节出血和关节镜检查的频率。
Blood Adv. 2018 Aug 28;2(16):2136-2144. doi: 10.1182/bloodadvances.2018020552.
2
Factors associated with pain severity, pain interference, and perception of functional abilities independent of joint status in US adults with hemophilia: Multivariable analysis of the Pain, Functional Impairment, and Quality of Life (P-FiQ) study.与美国血友病成人关节状况无关的疼痛严重程度、疼痛干扰和功能能力感知相关因素:疼痛、功能障碍和生活质量(P-FiQ)研究的多变量分析。
Eur J Haematol. 2018 Apr;100 Suppl 1:25-33. doi: 10.1111/ejh.13025.
3
康西珠单抗可改善A型血友病在血流状态下的凝血形成。
J Thromb Haemost. 2024 Sep;22(9):2438-2448. doi: 10.1016/j.jtha.2024.05.020. Epub 2024 May 28.
4
Patient perspective on living with mild hemophilia in Germany: results from a nationwide survey.德国血友病患者对轻度血友病生活的看法:一项全国性调查结果
Front Med (Lausanne). 2024 Feb 5;11:1347024. doi: 10.3389/fmed.2024.1347024. eCollection 2024.
Impact of pain and functional impairment in US adults with haemophilia: Patient-reported outcomes and musculoskeletal evaluation in the pain, functional impairment and quality of life (P-FiQ) study.
美国血友病成人患者疼痛和功能障碍的影响:疼痛、功能障碍和生活质量(P-FiQ)研究中的患者报告结局和肌肉骨骼评估。
Haemophilia. 2018 Mar;24(2):261-270. doi: 10.1111/hae.13377. Epub 2017 Dec 8.
4
Construct validity of patient-reported outcome instruments in US adults with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study.美国成年血友病患者自我报告结局工具的结构效度:疼痛、功能障碍和生活质量(P-FiQ)研究结果
Patient Prefer Adherence. 2017 Aug 9;11:1369-1380. doi: 10.2147/PPA.S141390. eCollection 2017.
5
Effect of late prophylaxis in hemophilia on joint status: a randomized trial.血友病晚期预防治疗对关节状况的影响:一项随机试验。
J Thromb Haemost. 2017 Nov;15(11):2115-2124. doi: 10.1111/jth.13811. Epub 2017 Oct 10.
6
The effects of joint disease, inhibitors and other complications on health-related quality of life among males with severe haemophilia A in the United States.在美国,关节疾病、抑制剂及其他并发症对重度甲型血友病男性患者健康相关生活质量的影响。
Haemophilia. 2017 Jul;23(4):e287-e293. doi: 10.1111/hae.13275. Epub 2017 Jun 2.
7
Self-reported prevalence, description and management of pain in adults with haemophilia: methods, demographics and results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study.血友病成年患者疼痛的自我报告患病率、描述及管理:疼痛、功能障碍和生活质量(P-FiQ)研究的方法、人口统计学特征及结果
Haemophilia. 2017 Jul;23(4):556-565. doi: 10.1111/hae.13214. Epub 2017 Apr 16.
8
Management of US men, women, and children with hemophilia and methods and demographics of the Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S) study.美国血友病男性、女性和儿童的管理以及“将血友病B的经验、结果和机会融入解决方案(B-HERO-S)”研究的方法和人口统计学特征。
Eur J Haematol. 2017 Apr;98 Suppl 86:5-17. doi: 10.1111/ejh.12854.
9
Impact of mild to severe hemophilia on education and work by US men, women, and caregivers of children with hemophilia B: The Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S) study.轻度至重度血友病对美国成年男性、女性以及B型血友病患儿照料者教育与工作的影响:“将B型血友病的经历、结果与机遇融入解决方案”(B-HERO-S)研究
Eur J Haematol. 2017 Apr;98 Suppl 86:18-24. doi: 10.1111/ejh.12851.
10
Impact of mild to severe hemophilia on engagement in recreational activities by US men, women, and children with hemophilia B: The Bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S) study.轻度至重度血友病对美国B型血友病男性、女性和儿童参与娱乐活动的影响:将B型血友病的经历、结果和机会融入解决方案(B-HERO-S)研究。
Eur J Haematol. 2017 Apr;98 Suppl 86:25-34. doi: 10.1111/ejh.12852.